The discovery that the human papilloma virus (HPV) is associated with a high and increasing
percentage of oropharyngeal squamous cell carcinomas (SCCs) is among the most …

Clinical trials frequently include multiple end points that mature at different times. The initial
report, typically based on the primary end point, may be published when key planned co-…

… Urban has received grants and personal fees from Boehringer Ingelheim, Roche, MSD,
and Bristol-Myers Squibb. Dr. Mishaeli has received personal fees from Boehringer Ingelheim, …

Human papilloma virus–positive oropharyngeal squamous cell carcinoma (HPV + OPSCC)
represents a distinct subgroup of head and neck cancers associated with clinical outcomes …

Context The use of the cannabis plant (Cannabis sativa L.) for the palliative treatment of
cancer patients has been legalized in multiple jurisdictions including Israel. Yet, not much is …

Aim Immune-related toxicities of immune checkpoint inhibitors (CPIs) require prompt
diagnosis and treatment. Atherosclerosis has an inflammatory component; we speculated this …

Introduction The use of postoperative radiotherapy (PORT) after resection of non–small-cell
lung cancer (NSCLC) is controversial, with some evidence suggesting a benefit in patients …

Cancer pain in the elderly population is an increasingly common clinical situation which
physicians are challenged with managing. Physiological changes occur with ageing affecting …

8534 Background: Resected NSCLC clinical stage I or II harbor a 5 year survival of only 30-50%.
Immunotherapy might be more effective in low-burden disease. We hypothesized that …

Objective Despite major progress over the past decade in the field of lung cancer care, only
mild advances have occurred in Small Cell Lung Cancer (SCLC), with prognosis remaining …